2011
DOI: 10.1016/j.pnpbp.2011.05.007
|View full text |Cite
|
Sign up to set email alerts
|

Acute and chronic effects of electroconvulsive treatment on oxidative parameters in schizophrenia patients

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1

Citation Types

1
23
0
3

Year Published

2013
2013
2019
2019

Publication Types

Select...
8
1

Relationship

1
8

Authors

Journals

citations
Cited by 22 publications
(27 citation statements)
references
References 47 publications
1
23
0
3
Order By: Relevance
“…While some have reported that antipsychotic medications used for schizophrenia have altered markers of oxidative stress, others have found no improvement [2426]. Interestingly, electroconvulsive therapy in schizophrenia patients reduces plasma thiobarbituric acid reactive substances, which is only evident months after the initial therapy [13]. …”
Section: Schizophreniamentioning
confidence: 99%
“…While some have reported that antipsychotic medications used for schizophrenia have altered markers of oxidative stress, others have found no improvement [2426]. Interestingly, electroconvulsive therapy in schizophrenia patients reduces plasma thiobarbituric acid reactive substances, which is only evident months after the initial therapy [13]. …”
Section: Schizophreniamentioning
confidence: 99%
“…2,3 Most of the studies investigating the mechanisms of ECT in the past 20 years have focused on biological theories. [4][5][6] Molecules in several brain areas are affected by ECT, including neurotransmitters, neuropeptides, and neurotrophic factors. 7 Understanding the mechanisms of action of ECT at the molecular level could lead to identification of response markers and potential new drug targets for more effective treatments.…”
mentioning
confidence: 99%
“…[12][13][14] Oxidative damage in the brain and decreased levels of antioxidants 15,16 may contribute, in part, to pathological changes in schizophrenia, suggesting antioxidative stress as a probable alternative approach to the pharmacological treatment of this disease. 6,13 Schwarz et al 17 proposed the helper T cell subtype 2 (T H 2) hypothesis, arguing that immunological findings in a subgroup of schizophrenia patients can be interpreted as a shift from T H 1-like cellular to T H 2-like humoral immune reactivity. Based on these hypotheses, 2 meta-analyses have been performed to investigate these associations of aberrant cytokine levels with schizophrenia.…”
mentioning
confidence: 99%
“…48 Oxidative stress has been implicated in the pathophysiological process of schizophrenia, with increased levels of lipid peroxides reported in subjects with schizophrenia. 51 Therefore, future studies should explore the balance between oxidative stress and neuroprotection as a key measure to understand the therapeutic potential of ECT in schizophrenia. 51 Therefore, future studies should explore the balance between oxidative stress and neuroprotection as a key measure to understand the therapeutic potential of ECT in schizophrenia.…”
Section: Neurotrophic Effects Of Antipsychotics and Ectmentioning
confidence: 99%